This article provides a broad frame of reference for analyzing most favoured nation (MNF) clauses, based on the case law and practice of the European courts and the European Commission. To read the article, click the link below.
Anticompetitive conduct and patents listed in the Orange Book
Branded pharmaceutical manufacturers are required by law to list all patents in the Orange Book that cover an approved drug product. However,...
